Passer au contenu principal

Thomas Kiss

Thomas Kiss

Clinical Associate Professor

Research Axes

Clinical research

Contact information

thomas.kiss@umontreal.ca

Originally from Switzerland, Thomas Kiss decided to contribute his skills and knowledge to the Hôpital Maisonneuve-Rosemont’s Transplant Program after completing his basic research training at the Ontario Institute for Cancer Research in Toronto, finishing his hematology and internal medicine training in Hamilton, Ontario, and working at the Princess Margaret Hospital in Toronto as a clinical fellow and then as a transplant hematologist. A clinical researcher and associate clinical professor, his professional activities regularly lead him to give lectures and presentations in the United States and Europe. He is a founding member of the Canadian Paroxysmal Nocturnal Hemoglobinuria (PNH) Network.

Research Unit

Dr. Kiss’s main areas of interest are allogeneic transplantation, acute leukemia and paroxysmal nocturnal hemoglobinuria (PNH), an extremely rare red blood cell disease. His research projects aim to improve transplantation in older patients and reduce post-transplant complications, such as thrombotic microangiopathy. He is also helping to develop algorithms and explore treatment options for PNH to improve patients’ overall survival rates and quality of life.

  • Lemieux C, Ahmad I, Bambace NM, Bernard L, Cohen S, Delisle JS, Fleury I, Kiss T, Mollica L, Roy DC, Sauvageau G, Roy J, Lachance S. Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Lymphoma Patients. BBMT, 26, (1), 157-161, January 2020. PMID: 31521818
  • LeBlanc R, Claveau JS, Ahmad I, Delisle JS, Bambace N, Bernard L, Cohen S, Kiss T, Lachance S, Landais S, Roy DC, Sauvageau G, Roy J. Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only. Clinical Transplantation 2020;34(12), e14099
  • Jean Sebastien Claveau, Richard LeBlanc, Imran Ahmad, Séverine Landais, Nadia M Bambace, Léa Bernard, Sandra Cohen, Jean-Sébastien Delisle, Thomas Kiss, Silvy Lachance, Denis-Claude Roy, Guy Sauvageau, Jean Roy. Myeloma patients relapsing after first line treatment with tandem auto/allo transplant or auto transplant only have similar outcomes. Biology of Blood and Marrow Transplantation 2020; 26(3) :S228-S229
  • Claveau JS, Cohen S, Ahmad I, Delisle JS, Kiss T, Lachance S, Sauvageau G, Busque L, Brito RM, Bambace N, Bernard L, Roy DC, Roy J. Single UM171 expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors. European Journal of Haematology 2020;105(6):808-811
  • Maude Dumont Lagace, Qi Li, Mégane Tanguay, Jalila Chagraoui, Tibila Kientega, Guillaume B Cardin, Ann Brasey, Assya Trofimov, Cédric Carli, Imran Ahmad, Nadia Bambace, Léa Bernard, Thomas L Kiss, Jean Roy, Denis‐Claude Roy, Sébastien Lemieux, Claude Perreault, Francis Rodier, Simon Frédéric Dufresne, Lambert Busque, Silvy Lachance, Guy Sauvageau, Sandra Cohen, Jean‐Sébastien Delisle. Single UM171 expanded cord blood transplants supprt robust T cell reconstitution with low rates of severe infections. Stem Cells Translational Medicine 2020; 9(suppl 1) :S8-S9
  • Sandra Cohen, Jean Roy, Silvy Lachance, Denis-Claude Roy, Lambert Busque, Fréderic Barabé, Imran Ahmad, Nadia M Bambace, Léa Bernard, Thomas L Kiss, Guy Sauvageau. UM171 epansion overcomes shortcomings of cord blood transplantation while maintaining benefits. Biology of Blood and Marrow Transplantation 2020;26(3)S294-S295
  • Maude Dumont Lagace, Qi Li, Mégane Tanguay, Jalila Chagraoui, Tibila Kientega, Guillaume B Cardin, Ann Brasey, Assya Trofimov, Cédric Carli, Imran Ahmad, Nadia M Bambace, Léa Bernard, Thomas L Kiss, Jean Roy, Denis-Claude Roy, Sébastien Lemieux, Claude Perreault, Francis Rodier,

    Simon Frédéric Dufresne, Lambert Busque, Silvy Lachance, Guy Sauvageau, Sandra Cohen, Jean-Sébastien Delisle. UM 171 expanded cord blood transplants support robust T cell reconstitution with low rates of severe infections. Biology of Blood and Marrow Transplantation 2021;27 (1). 76e1-76e9

Education

  • M.D.

    University of Basel

  • Doctor of Medicine

    University of Basel

  • Residency in internal medicine

    Solothurn

  • Research fellowship

    Ontario Institute for Cancer Research

  • Residency in internal medicine

    McMaster University

  • Internal medicine

    Royal College of Physicians and Surgeons of Canada (FRCPC)

  • Residency in hematology

    McMaster University

  • Bachelor of Medicine

    Medical Council of Canada (LMCC I and II)

  • Independent practice certificate

    College of Physicians and Surgeons of Ontario

  • Hematology

    Royal College of Physicians and Surgeons of Canada (FRCPC)

  • Restrictive permit

    Collège des médecins du Québec

  • Recognition of specialty equivalence for hematology and internal medicine

    Collège des médecins du Québec

  • Permit to practice

    Collège des médecins du Québec